Skip to content
OpenCapital
Get started

iRadimed IRMD Enterprise value

Enterprise value at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$43.06B-6.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%
ICU Medical logo
ICU MedicalICUI
$4.26B-10.6%
ITG
Integer HoldingsITGR
$4.4B-19.6%
AngioDynamics logo
AngioDynamicsANGO
$441.62M+30.5%
Lumexa Imaging Holdings, Inc. logo
Lumexa Imaging Holdings, Inc. LMRI
$1.74B—

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.2B+62.0%
P/E50.8×+13.4×
P/S13.9×+4.1×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0×0.0×
Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

$667.3Mmarket cap+$59.2Ktotal debt−$50.3Mcash and equivalents=$617.02M

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's enterprise value?
iRadimed (IRMD) reported enterprise value of $617.02M in Q1 2025.
How has iRadimed's enterprise value changed year-over-year?
iRadimed's enterprise value increased by 20.1% year-over-year, from $513.84M to $617.02M.
What is the long-term trend for iRadimed's enterprise value?
Over 4 years (2020 to 2024), iRadimed's enterprise value has grown at a 28.8% compound annual growth rate (CAGR), from $234.04M to $644.96M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.